Elucidating the Correlation of D-Dimer Levels with COVID-19 Severity: A Scoping Review

Wesam Ahmed Nasif1,2, Abeer Shaker El-Moursy Ali3, Mohammed Hasan Mukhtar1

  • 1Biochemistry Department, Faculty of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia.

Anemia
|March 21, 2022
PubMed

Insights

Elevated D-dimer levels in COVID-19 patients indicate increased thrombotic activity and are linked to disease severity. D-dimer may serve as a prognostic biomarker for better patient outcomes and reduced mortality.

Area of Science:

  • Biochemistry
  • Hematology
  • Infectious Diseases

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection triggers prothrombotic states.
  • D-dimer, a fibrin degradation product, reflects thrombotic activity.
  • Elevated D-dimer levels are associated with COVID-19 severity.

Purpose of the Study:

  • To review existing literature on the association between D-dimer levels and COVID-19 severity and prognosis.
  • To evaluate the efficacy of anticoagulant therapies in managing COVID-19.

Main Methods:

  • Comprehensive literature search of MEDLINE/PubMed, Scopus, and Web of Science.
  • Keywords included COVID-19, D-Dimer, Thrombosis, Fibrin network, Anticoagulant therapy, Inflammation, and disease severity.
  • Scoping review of retrieved articles and clinical experience.

Main Results:

  • D-dimer is a marker of thrombotic activity, formed from fibrin network degradation.
  • SARS-CoV-2 infection induces prothrombotic changes, correlating positively with D-dimer levels.
  • D-dimer levels are postulated to be associated with COVID-19 disease severity.

Conclusions:

  • D-dimer shows potential as a biomarker for predicting COVID-19 prognosis and outcomes.
  • Utilizing D-dimer for risk stratification can personalize clinical management.
  • Early identification via D-dimer may reduce mortality and accelerate recovery in COVID-19 patients.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
50
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
142
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
60
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
46